NO20053574L - Spleisevarianter av LGR6 - Google Patents
Spleisevarianter av LGR6Info
- Publication number
- NO20053574L NO20053574L NO20053574A NO20053574A NO20053574L NO 20053574 L NO20053574 L NO 20053574L NO 20053574 A NO20053574 A NO 20053574A NO 20053574 A NO20053574 A NO 20053574A NO 20053574 L NO20053574 L NO 20053574L
- Authority
- NO
- Norway
- Prior art keywords
- lgr6
- polypeptides
- methods
- splice variants
- provides
- Prior art date
Links
- 101000981765 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 6 Proteins 0.000 title 1
- 102100024140 Leucine-rich repeat-containing G-protein coupled receptor 6 Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000000168 G protein-coupled receptor 6 Human genes 0.000 abstract 1
- 108050008522 G protein-coupled receptor 6 Proteins 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43600102P | 2002-12-26 | 2002-12-26 | |
| PCT/EP2003/051091 WO2004058818A2 (fr) | 2002-12-26 | 2003-12-23 | Variants d'epissage de lgr6 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20053574L true NO20053574L (no) | 2005-07-21 |
Family
ID=32682312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053574A NO20053574L (no) | 2002-12-26 | 2005-07-21 | Spleisevarianter av LGR6 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060205924A1 (fr) |
| EP (1) | EP1587831A2 (fr) |
| JP (1) | JP2006523435A (fr) |
| AU (1) | AU2003303459A1 (fr) |
| CA (1) | CA2509568A1 (fr) |
| NO (1) | NO20053574L (fr) |
| WO (1) | WO2004058818A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006008009A2 (fr) * | 2004-07-23 | 2006-01-26 | Bayer Healthcare Ag | Agents diagnostiques et therapeutiques pour pathologies associees au gpcr 6 contenant la repetition riche en leucine (lgr6) |
| US8158757B2 (en) * | 2007-07-02 | 2012-04-17 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for treating and diagnosing cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US377391A (en) * | 1888-02-07 | Boot or shoe upper and method | ||
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| EP0590689B2 (fr) * | 1985-03-30 | 2006-08-16 | KAUFFMAN, Stuart A. | Procédé d'obtention d'ADN, ARN, peptides, polypeptides ou protéines, par une technique de recombinaison d'ADN |
| US6492107B1 (en) * | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| US5824469A (en) * | 1986-07-17 | 1998-10-20 | University Of Washington | Method for producing novel DNA sequences with biological activity |
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5272071A (en) * | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
| EP0950711A3 (fr) * | 1998-02-06 | 2003-09-17 | Akzo Nobel N.V. | Récepteurs de Gonadotropine |
| AU2001263020A1 (en) * | 2000-05-08 | 2001-11-20 | Millennium Pharmaceuticals, Inc. | G-protein coupled receptors and uses therefor |
| WO2002029038A2 (fr) * | 2000-10-04 | 2002-04-11 | Curagen Corporation | Nouvelles proteines, acides nucleiques codant ces derniers et anticorps diriges contre ces proteines |
| CA2439190A1 (fr) * | 2001-02-26 | 2002-09-06 | Shiaoping Zhu | Recepteurs couples a la proteine g isoles d'origine humaine, molecules d'acide nucleique codant les proteines gpcr humaines et utilisations de ces derniers |
-
2003
- 2003-12-23 JP JP2004563248A patent/JP2006523435A/ja not_active Withdrawn
- 2003-12-23 WO PCT/EP2003/051091 patent/WO2004058818A2/fr not_active Ceased
- 2003-12-23 EP EP03813927A patent/EP1587831A2/fr not_active Withdrawn
- 2003-12-23 US US10/540,808 patent/US20060205924A1/en not_active Abandoned
- 2003-12-23 AU AU2003303459A patent/AU2003303459A1/en not_active Abandoned
- 2003-12-23 CA CA002509568A patent/CA2509568A1/fr not_active Abandoned
-
2005
- 2005-07-21 NO NO20053574A patent/NO20053574L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1587831A2 (fr) | 2005-10-26 |
| WO2004058818A3 (fr) | 2004-09-16 |
| CA2509568A1 (fr) | 2004-07-15 |
| US20060205924A1 (en) | 2006-09-14 |
| AU2003303459A1 (en) | 2004-07-22 |
| WO2004058818A2 (fr) | 2004-07-15 |
| JP2006523435A (ja) | 2006-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2077279T3 (da) | Tymiske stromale lymfopoietinreceptormolekyler og anvendelser heraf | |
| NO20055847L (no) | Nye peptider som binder til erytiupoietinreseptoren | |
| WO2000070049A3 (fr) | Molecules de signalisation extracellulaires | |
| DK1383919T3 (da) | Fremgangsmåder og sammensætninger til anvendelse af MHC klasse II-invariant kædepolypeptid som en receptor for makrofag migrationsinhiberede faktor | |
| WO2002063005A3 (fr) | Molecules associees a des lipides | |
| WO2001068705A3 (fr) | Molecules du type recepteur de l'interleukine 17 et leurs utilisations | |
| WO2000012711A8 (fr) | Proteines membranaires de canal humaines | |
| WO2003094848A3 (fr) | Proteines associees a des acides nucleiques | |
| WO2001042474A3 (fr) | Molecules de type interferon et utilisations | |
| WO2002000723A3 (fr) | Molecules de recepteur de lymphopoietine de stroma thymique et utilisations de celles-ci | |
| DK1196442T3 (da) | VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser | |
| NO20053574L (no) | Spleisevarianter av LGR6 | |
| WO2000056891A3 (fr) | Proteines transmembranaires humaines | |
| WO2000060080A3 (fr) | Molecules du systeme immunitaire | |
| NO993653D0 (no) | Fremgangsmåte for diagnose, prognose og behandling av glaukom og relaterte sykdommer | |
| WO2004044165A3 (fr) | Proteines associees aux lipides | |
| WO2001032888A3 (fr) | Molecules humaines de la transferase | |
| WO2002083736A3 (fr) | Molecules du recepteur couple aux proteines g et utilisation desdites molecules | |
| MXPA03010728A (es) | Moleculas de proteina-2 relacionadas con b7 y uso de las mismas. | |
| WO2004053068A3 (fr) | Molecules de modification et de maintenance de proteines | |
| WO2004009797A3 (fr) | Molecules de modification et d'entretien de proteines | |
| WO2003063688A3 (fr) | Molecules de modification et d'entretien de proteines | |
| WO2000065054A3 (fr) | Proteines humaines associees aux membranes | |
| WO2002014489A3 (fr) | Molecules du recepteur 8 couple a la protenie g contenant des repetitions riches en leucines, et utilisations associees | |
| WO2002099108A3 (fr) | Molecules de type transporteur de cassette de liaison d'atp et leur utilisation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |